NewLake Capital: Lock In Yields As Cannabis Federal Rescheduling Likely Near Seeking Alpha NewLake Capital: Lock In Yields As Cannabis Federal Rescheduling Likely Near. Cannabis 4 weeks
Cannabis stocks rally after Trump supports moving drug to less restrictive category MarketWatch 1 week
Canopy Growth’s CEO Is Leaving: Is That a Sign of Trouble for the Cannabis Stock? The Motley Fool 3 weeks
Canopy Growth: Dilution, Executive Turnover, Cannabis Rescheduling Delay End High Seeking Alpha 3 weeks
Ascend Wellness becomes third cannabis company to jettison its chief executive this month MarketWatch 3 weeks
Cannabis stocks drop sharply as DEA sets drug-rescheduling hearing after November election MarketWatch 3 weeks
Tilray Brands Is Buying More Beer Brands, and Its Wheeling and Dealing Isn’t Over The Motley Fool 3 weeks
Cannabis Giant Tilray Expands its Craft Beer Stable With Acquisition of Four Molson Coors Brands Inc.com 4 weeks
Can Cannabis and Psilocybin Fix A Broken Healthcare System? AJNA Is Betting On It And You Can Be An Early Investor Too, With Just $250 For Under $2/Share Benzinga 4 weeks
Aurora Cannabis Had a Strong Q1, but Investors Should Expect a Slowdown in Future Quarters The Motley Fool 1 month
Cannabis company Tilray buys four Molson Coors brewers as it looks to become ‘beacon for craft brands’ MarketWatch 1 month
Canopy Growth stock drops on wider-than-expected loss but company sees growth opportunities in U.S. markets MarketWatch 1 month
Tilray Brands Could Finally Be On a Path to Profitability, and It’s All Thanks to This Strategic Move The Motley Fool 1 month
Curaleaf founder Boris Jordan to take over as CEO of largest U.S. cannabis company MarketWatch 1 month
Chicago-based cannabis giant Cresco Labs loss widens on $61 million charge for taxes MarketWatch 1 month
Earnings call: Chicago Atlantic affirms guidance amid cannabis market uncertainties Investing.com 1 month
Cannabis producer Demecan nears 100-million-euro valuation after fresh funding, source says Investing.com 1 month